• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / U.S. Equity

That's Just What's Supposed to Happen

Stocks that stabilized yesterday were terrific today.
By JIM CRAMER
Mar 05, 2015 | 04:22 PM EST
Stocks quotes in this article: PCYC, RCPT, ISIS, BMRN, REGN, SNY, ABBV, MNK, RHT, CRM, RRD

How about that? You got two down days and the stocks that stabilized midday yesterday -- the stocks where the bulls won the skirmishes -- acted terrific today, and that's just what is supposed to happen.

Can't get too distracted, though. The best-acting group today is the one that started advancing yesterday, and that's biotech.

Why not? There were three bidders for Pharmacyclics (PCYC) today and I think they all have to be eying Receptos (RCPT), Isis Pharma (ISIS), BioMarin (BMRN) and even Regeneron (REGN), despite its Sanofi (SNY) strangle.

Despite the pasting of AbbVie's (ABBV) stock, Mallinckrodt (MNK) shows you, once again, how to make acquisitions: small, bolt-on, immediately additive and adding another leg to the profit machine.

What's next? Perhaps a return to the high-multiple growth stocks after a severe hammering. Notice the strength in Red Hat (RHT) and Salesforce.com (CRM)? That's saying something.

Random Musings: Consider buying R.R. Donnelley (RRD) for growth and yield, it may have the single best combination in this market.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline on this article.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, is long ABBV and RHT.

TAGS: Investing | U.S. Equity

More from U.S. Equity

Wednesday's Woe, Biden's Plan, U.S. Dollar, J&J Vaccine, Trading Intel

Stephen Guilfoyle
Jan 14, 2021 7:22 AM EST

We are going to live again. You will dance in the aisle at some concert whose performer I have never heard of, and you will cheer for your favorite team in person again.

Federal Realty: Undervalued Dividend King With a High Yield

Bob Ciura
Jan 13, 2021 1:17 PM EST

There is a reason that there are just 30 Dividend Kings in the market.

Amid New Market Highs, Psychology and Valuation Warnings

Guy Ortmann
Jan 13, 2021 11:30 AM EST

Eager crowd buyers juxtaposed with actively selling insiders always raises a yellow flag.

Stock-Picking Becomes More Important in This Market Environment

Guy Ortmann
Jan 12, 2021 10:21 AM EST

All psychology data are now flashing caution signals.

Room of Nightmares, Political Reality, Bitcoin, Trading Boeing and Microsoft

Stephen Guilfoyle
Jan 12, 2021 7:37 AM EST

What you have seen over several weeks is a market reacting to improved prospects for increased fiscal support reliant upon deficit spending.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    When it's time to sell, will you act or freeze?
  • 08:35 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 1/13/2021

    Lower highs... SPX (Long-Term View) The 1/8/2...
  • 08:07 AM EST GARY BERMAN

    Tuesday Morning Fibocall for 1/12/2021

    Watch if the recent trend of lower highs continues...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login